Form 4: Aspira Women's Health Director Exercises Restricted Stock Units

Director Jannie Herchuk converted 8,437 restricted stock units into common stock of Aspira Women's Health Inc. on December 31, 2024.

Summary

• Jannie Herchuk, a director at Aspira Women's Health Inc., converted 8,437 restricted stock units (RSUs) into common stock on December 31, 2024.
• These RSUs were part of a grant of 33,750 RSUs awarded on August 22, 2024, with 8,437 vesting on December 31, 2024.
• The conversion resulted in Ms. Herchuk owning 65,627 shares of common stock directly.
• The RSUs were previously reported in a Form 4 filed on August 26, 2024.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to executive compensation, which is generally viewed neutrally to positively. The vesting of RSUs is a positive sign of performance.

Positives

• The vesting of RSUs indicates that performance milestones were likely met.
• The conversion of RSUs to common stock aligns the director's interests with those of shareholders.

Industry Context

This transaction is a routine part of executive compensation and aligns with standard practices for publicly traded companies.

Comparison to Industry Standards

• The vesting of restricted stock units is a common practice in executive compensation across various industries, including healthcare and biotechnology.
• Many companies use RSUs to incentivize and retain key personnel, aligning their interests with the long-term performance of the company.
• The specific vesting schedule and amounts may vary based on company size, performance, and industry benchmarks.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it aligns the director's interests with the company's performance.
• The vesting of RSUs is a positive sign for employees as it indicates the company is meeting its performance goals.

Key Dates

Keywords

Aspira Women's Health, Director, Restricted Stock Units, RSU, Stock Conversion, Beneficial Ownership, SEC Form 4